CD39/NTPDase-1 activity and expression in normal leukocytes

Thrombosis Research

Volumn 121, Issue 3, 2007, Pages 309-317

  Pulte, E Dianne ^a,b   Broekman, M Johan ^a,b   Olson, Kim E ^b   Drosopoulos, Joan H F ^a,b   Kizer, Jorge R ^b   Islam, Naziba ^a,b   Marcus, Aaron J ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

CD39; Lymphocytes; Thrombosis

Indexed keywords

CD39 ANTIGEN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL DENSITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ETHNIC GROUP; FEMALE; HUMAN; LEUKOCYTE; MALE; MEASUREMENT; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD; APYRASE; B-LYMPHOCYTES; BLOOD CHEMICAL ANALYSIS; CELL SEPARATION; CHROMATOGRAPHY, THIN LAYER; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MITOGENS; MONOCYTES; NEUTROPHILS; T-LYMPHOCYTES;

EID: 37749025228     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.04.008     Document Type: Article

References (29)

1. Marcus A.J., Broekman M.J., Drosopoulos J.H., Islam N., Alyonycheva T.N., Safier L.B., et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 99 (1997) 1351-1360
2. Kaczmarek E., Koziak K., Sevigny J., Siegel J.B., Anrather J., Beaudoin A.R., et al. Identification and characterization of CD39/vascular ATP diphosphohydrolase. J Biol Chem 271 (1996) 33116-33122
3. Maliszewski C.R., Delespesse G.J., Schoenborn M.A., Armitage R.J., Fanslow W.C., Nakajima T., et al. The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol 153 (1994) 3574-3583
4. Kansas G.S., Wood G.S., and Tedder T.F. Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J Immunol 146 (1991) 2235-2244
5. Olson K.E., Pulte E.D., Broekman M.J., Olson A.E., Drosopoulos J.H., Islam N., et al. CD39/NTPDase1 variants identified in human neutrophils regulate antithrombotic activity. Blood 106 11 (2005) 11-16 [Ref Type: Abstract]
6. Mizumoto N., Kumamoto T., Robson S.C., Sevigny J., Matsue H., Enjyoji K., et al. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 8 (2002) 358-365
7. Clifford E.E., Martin K.A., Dalal P., Thomas R., and Dubyak G.R. Stage-specific expression of P2Y receptors, ecto-apyrase, and ecto-5′-nucleotidase in myeloid leukocytes. Am J Physiol 273 (1997) C973-C987
8. Damle R.N., Ghiotto F., Valetto A., Albesiano E., Fais F., Yan X.J., et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 99 (2002) 4087-4093
9. Davi F., Delecluse H.J., Guiet P., Gabarre J., Fayon A., Gentilhomme O., et al. Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group. J Clin Oncol 16 (1998) 3788-3795
10. Leal D.B., Streher C.A., Bertoncheli C.M., Carli L.F., Leal C.A., da Silva J.E., et al. HIV infection is associated with increased NTPDase activity that correlates with CD39-positive lymphocytes. Biochim Biophys Acta 1746 (2005) 129-134
11. Pinsky D.J., Broekman M.J., Peschon J.J., Stocking K.L., Fujita T., Ramasamy R., et al. Elucidation of the thromboregulatory role of CD39/ectoapyrase in the ischemic brain. J Clin Invest 109 (2002) 1031-1040
12. El-Omar M.M., Islam N., Broekman M.J., Drosopoulos J.H., Roa D.C., Lorin J.D., et al. The ratio of ADP-to ATP-ectonucleotidase activity is reduced in patients with coronary artery disease. Thromb Res 116 (2005) 199-206
13. Marcus A.J., Broekman M.J., Drosopoulos J.H., Olson K.E., Islam N., Pinsky D.J., et al. Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost 31 (2005) 234-246
14. Marcus A.J., Broekman M.J., Drosopoulos J.H., Islam N., Alyonycheva T.N., Safier L.B., et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 99 (1997) 1351-1360
15. Langston H.P., Ke Y., Gewirtz A.T., Dombrowski K.E., and Kapp J.A. Secretion of IL-2 and IFN-gamma, but not IL-4, by antigen-specific T cells requires extracellular ATP. J Immunol 170 (2003) 2962-2970
16. Dombrowski K.E., Ke Y., Brewer K.A., and Kapp J.A. Ecto-ATPase: an activation marker necessary for effector cell function. Immunol Rev 161 (1998) 111-118
17. Goepfert C., Imai M., Brouard S., Csizmadia E., Kaczmarek E., and Robson S.C. CD39 modulates endothelial cell activation and apoptosis. Mol Med 6 (2000) 591-603
18. Chen Y., Corriden R., Inoue Y., Yip L., Hashiguchi N., Zinkernagel A., et al. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314 (2006) 1792-1795
19. Gayle III R.B., Maliszewski C.R., Gimpel S.D., Schoenborn M.A., Caspary R.G., Richards C., et al. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest 101 (1998) 1851-1859
20. Drosopoulos J.H., Broekman M.J., Islam N., Maliszewski C.R., Gayle III R.B., and Marcus A.J. Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39: requirement of glutamate 174 and serine 218 for enzyme activity and inhibition of platelet recruitment. Biochemistry 39 (2000) 6936-6943
21. Sembries S., Pahl H., Stilgenbauer S., Dohner H., and Schriever F. Reduced expression of adhesion molecules and cell signaling receptors by chronic lymphocytic leukemia cells with 11q deletion. Blood 93 (1999) 624-631
22. Pulte E.D., Olson K.E., Islam N., Broekman M.J., Ballard H., and Marcus A.J. Function of CD39 (NTPDase-1) in chronic lymphocytic leukemia. Blood 106 11 (2005) 11-16 [Ref Type: Abstract]
23. Luthje J., Schomburg A., and Ogilvie A. Demonstration of a novel ecto-enzyme on human erythrocytes, capable of degrading ADP and of inhibiting ADP-induced platelet aggregation. Eur J Biochem 175 (1988) 285-289
24. Marcus A.J., Safier L.B., Hajjar K.A., Ullman H.L., Islam N., Broekman M.J., et al. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. J Clin Invest 88 (1991) 1690-1696
25. Lindholm L., Ejlertsson G., and Schersten B. High risk of cerebro-cardiovascular morbidity in well treated male hypertensives. A retrospective study of 40-59-year-old hypertensives in a Swedish primary care district. Acta Med Scand 216 (1984) 251-259
26. Isles C.G., Walker L.M., Beevers G.D., Brown I., Cameron H.L., Clarke J., et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J Hypertens 4 (1986) 141-156
27. Lip G.Y. Hypertension and the prothrombotic state. J Hum Hypertens 14 (2000) 687-690
28. Baricordi O.R., Ferrari D., Melchiorri L., Chiozzi P., Hanau S., Chiari E., et al. An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 87 (1996) 682-690
29. Dwyer K.M., Deaglio S., Gao W., Friedman D., Strom T.B., and Robson S.C. CD39 and control of cellular immune responses. Purinergic Signal 3 (2007) 171-180